Pure Biologics SA (DE:PQB)
FRANKFURT:PQB
Pba-0111
Triple Negative Breast Cancer, Head And Neck Squamous Cell Carcinoma, Soft Tissue Sarcoma Adult
Early Phase I
Recruiting
A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors
Nov 19, 2024
―
Pba-0405
Triple Negative Breast Cancer, Head And Neck Squamous Cell Carcinoma, Soft Tissue Sarcoma Adult
Early Phase I
Completed
A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors
Feb 15, 2024
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Pure Biologics SA (PQB) have in its pipeline
PQB is currently developing the following drugs: Pba-0111, Pba-0405. These drug candidates are in various stages of clinical development as the company works toward FDA approval.